ArborGen Holdings (ARB) H1 2025 earnings summary

Executive summary

• Revenue for 1H25 declined 3% to $12.8m after a record 78% increase in 1H24, but remains well above 1H23 levels.

• Net loss after tax was $(2.1)m, compared to $(0.1)m in 1H24, reflecting softer market conditions and higher costs.

• Strategic progress included streamlining US operations, expanding nursery capacity in Brazil, and launching a share buyback.

• Brazil remains a key growth area, with ongoing investments in production capacity and a shift to higher-margin proprietary seedlings.

• Demonstrated resilience and delivered solid results despite challenging US South market conditions, leveraging advanced genetics for superior prices and margins.

Financial highlights

• Sales revenue: $12.8m (down 3% vs 1H24; up from $7.4m in 1H23).

• Net loss after tax was $(2.1)m for 1H25, compared to $(0.1)m in 1H24.

• Adjusted US GAAP EBITDA: $(2.7)m, excluding $2m in one-off items.

• Cost of sales increased 15% year-over-year due to higher US seed costs and inventory losses from weather events.

• Net debt increased to $19.9m from $16.7m in 1H24, mainly due to working capital timing and capex.

Outlook and guidance

• FY25 Adjusted US GAAP EBITDA expected between $8.5m and $10m, down from $12.8m in FY24.

• Softer sales volumes anticipated due to ongoing market headwinds in the US South, partially offset by expected growth in Brazil in 2H25.

• Long-term demand trends in both the US and Brazil remain positive, with recovery in US saw timber demand projected to start mid-2025.